Sign in
4

Changes in Ownership

XBiotech Inc. Filed Acc 0001209191-17-041609

Options or other derivatives

  • Chief Executive Officer acquired 75,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
SIMARD JOHN Chief Executive Officer 2017-06-19 Option exercise · Stock Option +75,000 $4.24 $318,000 75,000 D
Loading xslF345X03/doc4.xml…